Report Detail

Pharma & Healthcare Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Research Report 2021

  • RnM4300390
  • |
  • 05 April, 2021
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview

  • 1.1 Product Overview and Scope of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
  • 1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
    • 1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Live Vaccine
    • 1.2.3 Inactivated Vaccine
  • 1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
    • 1.3.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Government Tender
    • 1.3.3 Marketing
  • 1.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Estimates and Forecasts
    • 1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2027
    • 1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2027
    • 1.4.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competition by Manufacturers

  • 2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites, Area Served, Product Type
  • 2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation and Trends
    • 2.5.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue
    • 2.5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region

  • 3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
    • 3.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
    • 3.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
    • 3.4.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
    • 3.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
    • 3.5.2 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
    • 3.6.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
    • 3.6.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
    • 3.7.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Type

  • 4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
  • 4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2016-2021)

5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Application

  • 5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
  • 5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 CNADC
    • 6.1.1 CNADC Corporation Information
    • 6.1.2 CNADC Description and Business Overview
    • 6.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 CNADC Product Portfolio
    • 6.1.5 CNADC Recent Developments/Updates
  • 6.2 Boehringer-Ingelheim
    • 6.2.1 Boehringer-Ingelheim Corporation Information
    • 6.2.2 Boehringer-Ingelheim Description and Business Overview
    • 6.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Boehringer-Ingelheim Product Portfolio
    • 6.2.5 Boehringer-Ingelheim Recent Developments/Updates
  • 6.3 MSD Animal Health
    • 6.3.1 MSD Animal Health Corporation Information
    • 6.3.2 MSD Animal Health Description and Business Overview
    • 6.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 MSD Animal Health Product Portfolio
    • 6.3.5 MSD Animal Health Recent Developments/Updates
  • 6.4 Sinopharm
    • 6.4.1 Sinopharm Corporation Information
    • 6.4.2 Sinopharm Description and Business Overview
    • 6.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sinopharm Product Portfolio
    • 6.4.5 Sinopharm Recent Developments/Updates
  • 6.5 Ceva
    • 6.5.1 Ceva Corporation Information
    • 6.5.2 Ceva Description and Business Overview
    • 6.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Ceva Product Portfolio
    • 6.5.5 Ceva Recent Developments/Updates
  • 6.6 Chengdu Tianbang Biological Products Co., Ltd.
    • 6.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
    • 6.6.2 Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
    • 6.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Chengdu Tianbang Biological Products Co., Ltd. Product Portfolio
    • 6.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
  • 6.7 Tianjin Ruipu Biological Technology Co., Ltd.
    • 6.6.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
    • 6.6.2 Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
    • 6.6.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Product Portfolio
    • 6.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
  • 6.8 Qilu Animal Health
    • 6.8.1 Qilu Animal Health Corporation Information
    • 6.8.2 Qilu Animal Health Description and Business Overview
    • 6.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Qilu Animal Health Product Portfolio
    • 6.8.5 Qilu Animal Health Recent Developments/Updates
  • 6.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
    • 6.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
    • 6.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
    • 6.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Product Portfolio
    • 6.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
  • 6.10 CAVAC
    • 6.10.1 CAVAC Corporation Information
    • 6.10.2 CAVAC Description and Business Overview
    • 6.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 CAVAC Product Portfolio
    • 6.10.5 CAVAC Recent Developments/Updates
  • 6.11 Komipharm
    • 6.11.1 Komipharm Corporation Information
    • 6.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Komipharm Product Portfolio
    • 6.11.5 Komipharm Recent Developments/Updates
  • 6.12 Agrovet
    • 6.12.1 Agrovet Corporation Information
    • 6.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Agrovet Product Portfolio
    • 6.12.5 Agrovet Recent Developments/Updates
  • 6.13 Bioveta
    • 6.13.1 Bioveta Corporation Information
    • 6.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Bioveta Product Portfolio
    • 6.13.5 Bioveta Recent Developments/Updates
  • 6.14 Jinyu Bio-Technology
    • 6.14.1 Jinyu Bio-Technology Corporation Information
    • 6.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Jinyu Bio-Technology Product Portfolio
    • 6.14.5 Jinyu Bio-Technology Recent Developments/Updates
  • 6.15 Phibro Animal Health
    • 6.15.1 Phibro Animal Health Corporation Information
    • 6.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Phibro Animal Health Product Portfolio
    • 6.15.5 Phibro Animal Health Recent Developments/Updates
  • 6.16 Tiankang
    • 6.16.1 Tiankang Corporation Information
    • 6.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Tiankang Product Portfolio
    • 6.16.5 Tiankang Recent Developments/Updates
  • 6.17 Zoetis
    • 6.17.1 Zoetis Corporation Information
    • 6.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Zoetis Product Portfolio
    • 6.17.5 Zoetis Recent Developments/Updates
  • 6.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
    • 6.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
    • 6.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Product Portfolio
    • 6.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
  • 6.19 Plec Bioengineering Co., Ltd.
    • 6.19.1 Plec Bioengineering Co., Ltd. Corporation Information
    • 6.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
    • 6.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Plec Bioengineering Co., Ltd. Product Portfolio
    • 6.19.5 Plec Bioengineering Co., Ltd. Recent Developments/Updates

7 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis

  • 7.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
  • 7.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
  • 8.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers

9 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics

  • 9.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
  • 9.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Growth Drivers
  • 9.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
  • 9.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints

10 Global Market Forecast

  • 10.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
  • 10.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
  • 10.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Live Vaccine
    Inactivated Vaccine

    Segment by Application
    Government Tender
    Marketing

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    CNADC
    Boehringer-Ingelheim
    MSD Animal Health
    Sinopharm
    Ceva
    Chengdu Tianbang Biological Products Co., Ltd.
    Tianjin Ruipu Biological Technology Co., Ltd.
    Qilu Animal Health
    Guangdong Wens Dahuanong Biotechnology Co., Ltd.
    CAVAC
    Komipharm
    Agrovet
    Bioveta
    Jinyu Bio-Technology
    Phibro Animal Health
    Tiankang
    Zoetis
    Guangdong Yongshun Biological Pharmaceutical Co Ltd
    Plec Bioengineering Co., Ltd.


    Summary:
    Get latest Market Research Reports on Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS). Industry analysis & Market Report on Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is a syndicated market report, published as Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Research Report 2021. It is complete Research Study and Industry Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,103.08
    3,154.62
    4,206.16
    2,420.57
    3,630.85
    4,841.13
    315,514.20
    473,271.30
    631,028.40
    217,455.34
    326,183.01
    434,910.68
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report